# Kyntra Bio, Inc.: Form 8-K, filed Sep 2, 2025

- Company: [Kyntra Bio, Inc.](/companies/kynb.md) (CIK 921299)
- Form: 8-K
- Filed: 2025-09-02
- Accepted by EDGAR: Sep 2, 2025, 12:00 ET
- Period: 2025-08-29
- Accession: 0000950170-25-112341
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/921299/000095017025112341/fgen-20250829.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/921299/000095017025112341/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/921299/000095017025112341/fgen-20250829.htm

Filed Sep 2, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-112341. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.